Copper ion incorporation in α-synuclein amyloids

Area of Science:

• Neuroscience
• Biochemistry
• Biophysics

Background:

• Copper ion dys-homeostasis is implicated in neurodegenerative diseases like Parkinson's disease.
• Amyloid formation is a key pathological feature of Parkinson's disease, involving the protein alpha-synuclein.
• While copper binding to monomeric proteins is known, its interaction with amyloid fibers is less understood.

Purpose of the Study:

• To investigate the interactions between copper ions and alpha-synuclein amyloid fibers.
• To determine how copper incorporation affects the structure and properties of alpha-synuclein amyloids.
• To explore the implications of these interactions for Parkinson's disease pathogenesis and cellular protection.

Main Methods:

• In vitro studies using purified alpha-synuclein protein.
• Biophysical methods to analyze protein-metal interactions and amyloid structure.
• Investigation of alpha-synuclein variants with modified copper-binding sites.

Main Results:

• Copper (Cu(II)) binds tightly to monomeric alpha-synuclein and is readily incorporated into amyloid fibers, both during and after formation.
• Incorporation efficiency depends on specific copper-binding residues (N-terminus and His50) in alpha-synuclein.
• Copper incorporation alters amyloid morphology, secondary structure, proteinase sensitivity, and copper's chemical properties.

Conclusions:

• Alpha-synuclein amyloids can chelate copper ions, potentially contributing to copper dys-homeostasis observed in Parkinson's disease.
• Amyloid-copper interactions might offer neuroprotection by sequestering toxic free copper ions and preventing reactive oxygen species formation.